Key Market Indicator:
F&G: 40
25.233,35 NASDAQ · 48.573,00 DOW · 6.841,40 S&P · 4.299,43 Gold · 61,01 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
BE0974487192
Filter zurücksetzen
© ActuNews
01.12.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion verzekert een bindende financieringsfaciliteit van EUR 30 miljoen voor investeringen in digitale activa en crypto activa
Article
News Preview
Leuven, BELGIË – 1 december 2025 – 8u00 CET Oxurion NV (Euronext Brussel: OXUR), een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, kondigt de ondertekening aan van een inschrijvingsovereenkomst met Atlas Capital Markets betreffende een financiering via converteerbare obligaties, voor een totaalbedrag van &eur...
Themefolio
Profiler
Peergroup
© ActuNews
01.12.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion sécurise un financement ferme de 30 millions d'euros dédié à des investissements dans les actifs numériques et crypto actifs
Article
News Preview
Louvain, BELGIQUE – 1er décembre 2025 – 8h00, Oxurion NV (Euronext Bruxelles : OXUR), société de sous-traitance pharmaceutique basée à Louvain, annonce la signature d'un accord de souscription avec Atlas Capital Markets portant sur un financement en obligations convertibles d'un montant total d...
Themefolio
Profiler
Peergroup
© ActuNews
01.12.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
Article
News Preview
Leuven, BELGIUM – December 1 , 2025 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the signing of a subscription agreement with Atlas Capital Markets for a financing via convertible bonds, for a total amount of €30 million, divided into 12 tranches of ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ActuNews
25.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 25 november 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ActuNews
25.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – November 25, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 25, 2025, from Atlas Special Op...
Themefolio
Profiler
Peergroup
© ActuNews
20.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 20 november 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© ActuNews
20.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – November 20, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 20, 2025, from Atlas Special Op...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
Article
News Preview
Leuven, BELGIUM, November 3, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the termination of discussions regarding the planned acquisition of a company specialized in preclinical microbiology services (see press release dated June 19, 2025 – link). Following a thor...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion met fin aux discussions relatives à une transaction ciblée en préclinique annoncée précédemment et poursuit l'intégration d'un acteur clinique stratégique
Article
News Preview
Louvain, BELGIQUE – 3 novembre 2025 – 18h00 – Oxurion NV (Euronext Bruxelles : OXUR), société de sous-traitance pharmaceutique basée à Louvain, annonce la fin des discussions relatives à l'acquisition projetée d'une société spécialisée dans les services...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion beëindigt gesprekken over eerder aangekondigde preklinische overname en zet integratie voort van een strategische klinische speler
Article
News Preview
Leuven, BELGIË, 3 november 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, maakt bekend dat het de gesprekken heeft beëindigd met betrekking tot de overwogene overname van een vennootschap gespecialiseerd in preklinische microbiologische diensten (zie persbericht...
Themefolio
Profiler
Peergroup
© ActuNews
23.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 23 oktober 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© ActuNews
23.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – October 23, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on October 22, 2025, from Atlas Special Oppor...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ActuNews
17.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 17 oktober 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgevin...
Themefolio
Profiler
Peergroup
© ActuNews
17.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC Leuven, BELGIUM – October 17, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows...
Themefolio
Profiler
Peergroup
© ActuNews
16.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 16 oktober 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgevin...
Themefolio
Profiler
Peergroup
© ActuNews
16.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – October 16, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on October 15, 2025, from Atlas Special Oppor...
Themefolio
Profiler
Peergroup
© ActuNews
15.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – 15 October, 2025 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007...
Themefolio
Profiler
Peergroup
© ActuNews
15.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 4 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 100.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1. Leuven, BELGIUM– 15 oktober 2025 – 18u00 CET – Overeenkomstig artikel 15 van de...
Themefolio
Profiler
Peergroup
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een CRO die sterk complementair is aan Axiodis
Article
News Preview
Leuven, BELGIË, 13 oktober 2025, 18u30 – Oxurion NV (Euronext Brussel: OXUR) kondigt vandaag de ondertekening aan van een intentieverklaring (Letter of Intent, LOI) met het oog op de overname van een meerderheidsbelang in een Franse Contract Research Organization (CRO), gespecialiseerd in klinische ontwikkeling en regelgevende aangelegen...
Themefolio
Profiler
Peergroup
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO dotée d'une forte complémentarité avec Axiodis
Article
News Preview
Louvain, BELGIQUE – 13 octobre 2025 – 18h30 – Oxurion NV (Euronext Bruxelles : OXUR), société biopharmaceutique basée à Louvain, annonce la signature d'une lettre d'intention (LOI) en vue de l'acquisition d'une participation majoritaire dans une Contract Research Organization (CRO) fran&...
Themefolio
Profiler
Peergroup
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis
Article
News Preview
Leuven, BELGIUM, October 13, 2025, 6:30 PM – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company based in Leuven, announces the signing of a letter of intent (LOI) to acquire a majority stake in a French Contract Research Organization (CRO) specialized in clinical development and regulatory affairs. This potential transaction is...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion provides an update related to its investment strategy in digital assets
Article
News Preview
Leuven, BELGIUM, October 9, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces today that the completion of the new financing aimed at investing in digital assets (Bitcoin and Ethereum), originally scheduled to close on September 25, 2025, is still in progress. Administrative and compliance-related procedures (notably KYC/AML chec...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion annonce une mise à jour de sa stratégie d'investissement dans des actifs numériques
Article
News Preview
Louvain, BELGIQUE, 9 octobre 2025, 18h00 - Oxurion NV (Euronext Bruxelles : OXUR), annonce aujourd'hui que la finalisation du nouveau financement visant à investir dans des actifs numériques (Bitcoin et Ethereum), dont le closing avait été annoncé pour le 25 septembre 2025, est toujours en cours. Les ét...
Themefolio
Profiler
Peergroup
© ActuNews
09.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion geeft een update met betrekking tot de strategie voor investering in digitale activa
Article
News Preview
Leuven, BELGIË, 9 oktober 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt vandaag aan dat de afronding van de nieuwe financiering gericht op investeringen in digitale activa (Bitcoin en Ethereum), waarvan de closing oorspronkelijk gepland was op 25 september 2025, nog in voorbereiding is. De administratieve en compliance-gerela...
Themefolio
Profiler
Peergroup
© ActuNews
03.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 4 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 100.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1. Leuven, BELGIUM– 3 oktober 2025 – 18u00 CET – Overeenkomstig artikel 15 van de W...
Themefolio
Profiler
Peergroup
© ActuNews
03.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – 3 October, 2025 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 o...
Themefolio
Profiler
Peergroup
© ActuNews
02.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 2 oktober 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving o...
Themefolio
Profiler
Peergroup
© ActuNews
02.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – October 2, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification as follows: Oxurion received a transparency notification on October 2, 2025, from Atlas Special Opportun...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion maakt halfjaarresultaten 2025 bekend
Article
News Preview
Leuven, BELGIË – 30 September 2025 – 18:00 CET Oxurion NV (Euronext Brussel: OXUR) (de Vennootschap), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2025. Het halfjaarverslag is beschikbaar in de rubriek ‘Investe...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion publie ses résultats du premier semestre 2025
Article
News Preview
Louvain, BELGIQUE – 30 Septembre, 2025 – 18:00 CET - Oxurion NV (Euronext Brussels: OXUR), entreprise biopharmaceutique basée à Louvain, a publié aujourd'hui ses résultats financiers et opérationnels pour le semestre clos le 30 Juin 2025. Le rapport semestriel est disponible dans la section ‘...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Publishes First Half 2025 Results
Article
News Preview
Leuven, BELGIUM – September 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2025. The half-year report is available in the ‘Investors' section of the Company's webs...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques
Article
News Preview
Lancement de jumeaux numériques et de patients virtuels pour accélérer et fiabiliser les essais cliniques. Intégration de briques d'IA dans Exagis, solution eCRF propriétaire d'Axiodis. Leuven, BELGIQUE, 16 septembre 2025, 18h00 - Oxurion NV (Euronext Bruxelles : OXUR), annonce que sa filiale Axiodis CR...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
Article
News Preview
• Launch of digital twins and virtual patients to accelerate and enhance clinical trials • Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution Leuven, BELGIUM, September 16, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces that its subsidiary, Axiodis CRO, specialized in clinical data manageme...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep, kondigt een dubbele strategische AI-initiatieven aan om klinische proeven te transformeren
Article
News Preview
• Lancering van digitale tweelingen en virtuele patiënten om klinische studies te versnellen en te beveiligen • Integratie van AI-modules in Exagis, de eigen eCRF-oplossing van Axiodis Leuven, BELGIË, 16 september 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt aan dat zijn dochtervennootschap Axiodis CRO, gespec...
Themefolio
Profiler
Peergroup
© ActuNews
08.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 8 september 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transpar...
Themefolio
Profiler
Peergroup
© ActuNews
08.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – September 8, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification as follows: Oxurion received a transparency notification on September 3, 2025, from...
Themefolio
Profiler
Peergroup
© ActuNews
01.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 1 september 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transp...
Themefolio
Profiler
Peergroup
© ActuNews
01.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – September 1, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on August 28, 2025, from A...
Themefolio
Profiler
Peergroup
© ActuNews
01.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025
Article
News Preview
Leuven, BELGIUM – September 1, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that negotiations with Atlas Special Opportunities regarding the financing agreement are progressing constructively. The company expects to close the transaction before September...
Themefolio
Profiler
Peergroup
© ActuNews
01.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion confirme l'avancée des négociations relatives à sa stratégie de diversification de sa trésorerie ; un closing de l'opération est envisagé avant le 25 septembre 2025
Article
News Preview
Louvain, Belgique, 1er septembre 2025, 18h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce que les négociations avec Atlas Special Opportunities autour de la convention de financement avancent de manière constructive. La société envisage un closing de l'o...
Themefolio
Profiler
Peergroup
© ActuNews
01.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion bevestigt de vooruitgang van de onderhandelingen over haar strategie voor de diversificatie van de kasmiddelen; closing van de transactie wordt vóór 25 september 2025 verwacht
Article
News Preview
Leuven, BELGIË – 1 september 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, kondigt aan dat de onderhandelingen met Atlas Special Opportunities over de financieringsovereenkomst constructief verlopen. De vennootschap verwacht de transactie vóó...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van UBS Group AG
Article
News Preview
Leuven, BELGIË – 7 augustus 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transpa...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from UBS Group AG
Article
News Preview
Leuven, BELGIUM – August 7, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on August 1, 2025, from UBS G...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion beëindigt RD-programma voor geografische maculaire degeneratie en focust op nieuwe CRO-activiteiten
Article
News Preview
Leuven, België, 7 augustus 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutische vennootschap gevestigd in Leuven, kondigt vandaag de definitieve stopzetting aan van zijn preklinisch onderzoeksprogramma gericht op de ontwikkeling van nieuwe therapeutische doelwitten voor geografische maculaire degeneratie (GA). Dit pro...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Ends RD Program in Geographic Atrophy and Refocuses on New CRO Activities
Article
News Preview
Leuven, BELGIUM – August 7, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced the definitive termination of its preclinical research program aimed at developing new therapeutic targets for geographic atrophy (GA). This program relied on a high-throughput gene...
Themefolio
Profiler
Peergroup
© ActuNews
07.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion met fin à son programme de RD sur la dégénérescence maculaire géographique et se recentre sur ses nouvelles activités de CRO
Article
News Preview
Louvain, Belgique, 7 août 2025, 18h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce aujourd'hui la cessation définitive de son programme de recherche préclinique dédié au développement de nouvelles cibles thérapeutiques pour la d&eacut...
Themefolio
Profiler
Peergroup
© ActuNews
06.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – August 6, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on August 6, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
06.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 6 augustus 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transpa...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion obtient une offre de financement revue à la hausse à 30 M EUR pour lancer la diversification de sa trésorerie en actifs numériques
Article
News Preview
Louvain, Belgique, 4 août 2025, 18h00, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce avoir reçu une offre indicative de financement renforcée de la part d'Atlas Special Opportunities, portant sur un montant total de 30 millions d'euros. Cette proposition pr&ea...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion kondigt aan dat het een verbeterd indicatief financieringsaanbod van EUR 30 miljoen heeft gekregen om de diversificatie van een deel van zijn kasmiddelen naar digitale activa te starten
Article
News Preview
Leuven, BELGIË, 4 augustus 2025 – 18u00 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, kondigt aan dat het een verbeterd indicatief financieringsaanbod heeft ontvangen van Atlas Special Opportunities, voor een totaalbedrag van €30 miljoen. De voorgestelde f...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Article
News Preview
Leuven, Belgium, August 4, 2025 – 06:00 PM CEST – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces that it has received an improved indicative financing offer from Atlas Special Opportunities for a total amount of €30 million. The proposed financing would be structured in 10 successi...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion finalise l'acquisition d'Axiodis CRO et accélère la structuration de son pôle européen dédié à la donnée clinique
Article
News Preview
Oxurion annonce la réalisation complète de l'acquisition de 72?% du capital d'Axiodis CRO Cette opération marque la première étape dans la constitution d'un pôle intégré centré sur la donnée clinique Le Groupe intensifie les discussions avec d'autres cibles s...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Article
News Preview
Oxurion announces the full completion of the acquisition of a 72% equity stake in Axiodis CRO This transaction marks the first step in building an integrated platform focused on clinical data The Group is intensifying discussions with additional strategic targets in France and across Europe Leuven, Belgium, August 4, 2025 – 08:30 CEST &nd...
Themefolio
Profiler
Peergroup
© ActuNews
04.08.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Article
News Preview
Oxurion kondigt de volledige afronding aan van de overname van 72% van het aandelenkapitaal van Axiodis CRO. Deze overnamne vormt de eerste stap in de uitbouw van een geïntegreerd platform rond klinische data. De Groep versnelt de gesprekken met aanvullende strategische partners in Frankrijk en de rest Europa. Leuven, BELGIË, 4 augu...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 30 juli 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparanti...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – July 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on July 29, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 12 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 300.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1 die aan Oxurion zal toelaten om te focussen op het ontwikkelen van innovatieve geneesmiddelen om h...
Themefolio
Profiler
Peergroup
© ActuNews
30.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 12 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential m...
Themefolio
Profiler
Peergroup
© ActuNews
25.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 10 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 250.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1 die aan Oxurion zal toelaten om te focussen op het ontwikkelen van innovatieve geneesmiddelen om h...
Themefolio
Profiler
Peergroup
© ActuNews
25.07.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 10 convertible bonds in Oxurion resulting in a EUR 250,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential m...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 13.12.2025, Calendar Week 50, 347th day of the year, 18 days remaining until EoY.